The retrieved results are relevant but focus on HIV-positive patients. I'll now supplement with my comprehensive clinical knowledge on neonatal varicella to deliver a full answer.
Neonatal Varicella: Treatment & Management
Background
Neonatal varicella occurs when a newborn is infected with varicella-zoster virus (VZV), either perinatally (via maternal infection near delivery) or postnatally (via community exposure). The perinatal form — when maternal varicella develops 5 days before to 2 days after delivery — carries the highest mortality risk (up to 30% untreated) because the neonate receives virus without protective maternal antibodies.
Risk Stratification
| Timing of Maternal Rash | Risk to Neonate |
|---|
| >5 days before delivery | Low — maternal antibodies transferred |
| 5 days before to 2 days after delivery | High — neonatal varicella with dissemination risk |
| After day 2 postpartum | Moderate — some antibody transfer likely |
1. Prophylaxis (Post-Exposure)
Varicella-Zoster Immune Globulin (VariZIG)
Indications (AAP Red Book):
- Neonates whose mothers develop varicella 5 days before to 2 days after delivery
- Premature infants (≥28 weeks gestation) exposed postnatally whose mothers have no history of varicella/vaccination
- Premature infants (<28 weeks gestation or ≤1,000 g) exposed postnatally, regardless of maternal history
Dosing:
- VariZIG: 125 units IM, given as soon as possible (within 96 hours of exposure; some guidelines allow up to 10 days)
If VariZIG is unavailable, IVIG 400 mg/kg IV as a single dose is an acceptable alternative.
2. Active Treatment
Acyclovir IV — Drug of Choice
All neonates with active varicella (clinical disease present) require IV acyclovir regardless of severity, given high risk of dissemination to viscera, lungs, liver, and CNS.
| Parameter | Detail |
|---|
| Drug | Acyclovir IV |
| Dose | 10 mg/kg IV every 8 hours (1-hour infusion) |
| Duration | 10–14 days (extend if CNS involvement confirmed) |
| Initiation | As soon as lesions appear — do NOT wait for dissemination |
(Prevention and Treatment of Opportunistic Infections in Children with and Exposed to HIV, p. 430)
CNS/Disseminated Disease
- LP should be performed if encephalitis or meningitis is suspected
- Extend acyclovir to 21 days if CSF is positive for VZV DNA by PCR
- Monitor renal function and ensure adequate hydration (acyclovir is nephrotoxic with inadequate hydration)
3. Isolation & Supportive Care
- Isolate the neonate in a negative-pressure room or strict contact/airborne precautions
- Separate from mother until all maternal lesions are crusted and neonate has received VariZIG
- Avoid breastfeeding if active lesions are present on the breast (expressed milk is acceptable if no lesions)
- Supportive care: antipyretics (avoid aspirin — Reye syndrome risk), wound care, monitor for secondary bacterial superinfection
4. Monitoring for Complications
| Complication | Monitoring |
|---|
| Pneumonitis | Chest X-ray, O₂ saturation |
| Hepatitis | LFTs |
| Encephalitis | Neurological assessment, EEG, MRI, LP |
| Disseminated intravascular coagulation (DIC) | CBC, coagulation panel |
| Secondary bacterial skin infection | Blood cultures if febrile |
5. Congenital Varicella Syndrome (CVS)
Distinct from neonatal varicella — results from maternal infection in first 20 weeks of gestation (peak risk 13–20 weeks). Features include:
- Skin scarring in dermatomal distribution
- Limb hypoplasia
- Ocular defects (chorioretinitis, microphthalmia)
- CNS abnormalities (cortical atrophy, seizures)
- No specific antiviral treatment alters outcomes for CVS; management is supportive/rehabilitative
Summary Algorithm
Maternal varicella 5 days before → 2 days after delivery?
↓ YES
→ Give VariZIG 125 units IM to neonate ASAP (within 96 hrs)
→ Monitor closely for 10–21 days
Neonate develops varicella lesions?
↓ YES
→ Admit + Airborne/Contact isolation
→ Acyclovir 10 mg/kg IV q8h × 10–14 days (21 days if CNS involved)
→ LFTs, CBC, CXR, consider LP
→ Hydration + supportive care
Key takeaway: Any neonate with active varicella should receive IV acyclovir immediately. VariZIG is preventive and most effective when given within 96 hours of exposure in high-risk neonates. Early treatment dramatically reduces mortality from the previously high untreated rate of ~30%.